New Jersey Law Journal names Parvin K. Aminolroaya among the “Top Women in Law”

Seeger Weiss LLP is proud to announce that partner Parvin K. Aminolroaya has been recognized among New Jersey Law Journal’s “Top Women in Law.” “I’m honored to be recognized alongside these incredibly accomplished lawyers,” says Aminolroaya. Only twenty were selected, among them law professors, in-house counsel, and members of the U.S. Attorney’s Office for the […]

October 23, 2020

Parvin Aminolroya

Seeger Weiss LLP is proud to announce that partner Parvin K. Aminolroaya has been recognized among New Jersey Law Journal’s “Top Women in Law.”

“I’m honored to be recognized alongside these incredibly accomplished lawyers,” says Aminolroaya. Only twenty were selected, among them law professors, in-house counsel, and members of the U.S. Attorney’s Office for the District of New Jersey.

A litigator at Seeger Weiss for more than a decade, Aminolroaya has brought her extensive background in class action consumer and mass tort matters to bear on many of the biggest cases before the country. Her work includes serving in key trial, discovery, and expert development roles, including discovery negotiations, depositions, expert development, brief writing, and trial preparation. She has represented a wide spectrum of plaintiffs in such significant matters as litigation against makers of opioid drugs, representing counties and municipalities whose health and hospital systems have been severely tested by the epidemic of drug abuse; litigation against 3M over allegations that the manufacturer sold defective earplugs both to the military for use in battle situations and to civilians for high noise exposure situations; and litigation against Volkswagen and other carmakers for disguising the actual emission levels of their diesel engine cars, resulting several multi-billion dollar settlements; among others.

“I find my work so meaningful,” Aminolroaya says. “Cases like In re National Prescription Opiate Litigation seek to recover funds for state and local governments addressing the harm to their communities caused by defendants’ conduct. It’s work that impacts entire country.”

New Jersey Law Journal will be publishing a special supplement later this year that will spotlight the honorees, their accomplishments, and their insights. New Jersey Law Journal last published a “Top Women in Law” feature in 2018.

No aspect of this advertisement has been approved by the Supreme Court of New Jersey or a court or authority of any jurisdiction.

Related News

March 12, 2026
Seeger Weiss Partner Parvin Aminolroaya and Counsel Max Kelly Appointed to Leadership Roles in GLP-1 NAION Products Liability Litigation

Seeger Weiss is proud to announce that Partner Parvin Aminolroaya has been appointed Co-Lead Counsel for Plaintiffs in the In Re: GLP-1 RAS Non-arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation and Counsel Max Kelly has been appointed to the Plaintiffs’ Executive Committee. The litigation involves claims that GLP-1 receptor agonist drugs including Ozempic, Wegovy, […]

Read More
February 18, 2026
Twelve Seeger Weiss Attorneys Named to The 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers Guide

Seeger Weiss is proud to announce that twelve Seeger Weiss attorneys have been selected for inclusion in the 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers guide. Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Steven Daroci, Scott Alan George, Shauna Itri, Diogenes P. Kekatos, Michael L. Rosenberg, Jennifer Scullion, […]

Read More
February 17, 2026
$7.25 Billion Nationwide Roundup / Glyphosate Class Action Settlement To Provide Compensation To Those Diagnosed With Non-Hodgkin Lymphoma After Exposure To Weedkiller

ST. LOUIS, MO – A proposed nationwide class-action settlement resolving claims that exposure to Roundup herbicides caused non-Hodgkin lymphoma (NHL) was filed today in the 22nd Judicial Circuit Court for the City of St. Louis, Missouri. The settlement would make up to $7.25 billion available to compensate individuals across the United States who were exposed […]

Read More